Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

44.08
+0.18000.41%
Volume:1.57K
Turnover:69.19K
Market Cap:39.67M
PE:- -
High:44.08
Open:44.08
Low:44.08
Close:43.90
52wk High:44.10
52wk Low:13.42
Shares:900.00K
Float Shares:900.00K
Volume Ratio:1.66
T/O Rate:0.17%
Dividend:0.65
Dividend Rate:1.48%
ROE:--
ROA:--
PB:0.90
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Virtus LifeSci Biotech Clinical Trials ETF
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
- -
Office Location:
One Financial Plaza,26th Floor,Hartford,Connecticut,United States
Website:
- -
Zip Code:
06103
Fax:
860-241-1024
Introduction:
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.